Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Granite Bio AG

History from 10 May 2021

UID
CHE-465.152.120
Legal form
AG
Canton
BS
Founded
10 May 2021
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 927k
232k464k695k927k15 Jul 2022 · CHF 385k25 Nov 2022 · CHF 392k5 Oct 2023 · CHF 404k26 Oct 2023 · CHF 723k14 Oct 2025 · CHF 923k6 Jul 2026 · CHF 927kRound announced 25 Apr 20252023202420252026
  • shares
  • Vorzugsaktien A
  • Vorzugsaktien B
  • round announced

Record

  1. SHAB published 14 May 2021 · legal date 10 May 2021

    Company formed

    Founded 10 May 2021

    SHAB HR01-1005180975 ↗

  2. SHAB published 15 Jul 2022 · legal date 7 Jul 2022

    Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    235’000 → 385’000
    Shares
    23’500’000 → 38’500’000
    New shares, % of post-step shares
    39.0% (15’000’000 new)
    Share classes
    8’500’000 × CHF 0.01 · 30’000’000 × CHF 0.01 Vorzugsaktien A

    Aktienkapital neu: CHF 385'000.00 [bisher: CHF 235'000.00]. Liberierung Aktienkapital neu: CHF 385'000.00 [bisher: CHF 235'000.00]. Aktien neu: 8'500'000 Namenaktien zu CHF 0.01 und 30'000'000 Namenaktien zu CHF 0.01 (Vorzugsaktien A) [bisher: 8'500'000 Namenaktien zu CHF 0.01 und 15'000'000 Namenaktien zu CHF 0.01 (Vorzugsaktien A)].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005521982 ↗

  3. SHAB published 25 Nov 2022 · legal date 21 Nov 2022

    Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    385’000 → 391’604
    Shares
    38’500’000 → 39’160’400
    New shares, % of post-step shares
    1.7% (660’400 new)
    Share classes
    9’160’400 × CHF 0.01 · 30’000’000 × CHF 0.01 Vorzugsaktien A

    Aktienkapital neu: CHF 391'604.00 [bisher: CHF 385'000.00]. Liberierung Aktienkapital neu: CHF 391'604.00 [bisher: CHF 385'000.00]. Aktien neu: 9'160'400 Namenaktien zu CHF 0.01 und 30'000'000 Namenaktien zu CHF 0.01 (Vorzugsaktien A) [bisher: 30'000'000 Namenaktien zu CHF 0.01 (Vorzugsaktien A) und 8'500'000 Namenaktien zu CHF 0.01].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005612993 ↗

  4. SHAB published 5 Oct 2023 · legal date 28 Sep 2023

    Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    391’604 → 404’176.44
    Shares
    39’160’400 → 40’417’644
    New shares, % of post-step shares
    3.1% (1’257’244 new)
    Share classes
    10’417’644 × CHF 0.01 · 30’000’000 × CHF 0.01 Vorzugsaktien A

    Aktienkapital neu: CHF 404'176.44 [bisher: CHF 391'604.00]. Liberierung Aktienkapital neu: CHF 404'176.44 [bisher: CHF 391'604.00]. Aktien neu: 10'417'644 Namenaktien zu CHF 0.01 und 30'000'000 Namenaktien zu CHF 0.01 (Vorzugsaktien A) [bisher: 30'000'000 Namenaktien zu CHF 0.01 (Vorzugsaktien A) und 9'160'400 Namenaktien zu CHF 0.01].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005853380 ↗

  5. SHAB published 26 Oct 2023 · legal date 18 Oct 2023

    Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    404’176.44 → 723’224.06
    Shares
    40’417’644 → 72’322’406
    New shares, % of post-step shares
    44.1% (31’904’762 new)
    Share classes
    10’417’644 × CHF 0.01 · 30’000’000 × CHF 0.01 Vorzugsaktien A · 31’904’762 × CHF 0.01 Vorzugsaktien B

    Aktienkapital neu: CHF 723'224.06 [bisher: CHF 404'176.44]. Liberierung Aktienkapital neu: CHF 723'224.06 [bisher: CHF 404'176.44]. Aktien neu: 10'417'644 Namenaktien zu CHF 0.01, 30'000'000 Namenaktien zu CHF 0.01 (Vorzugsaktien A) und 31'904'762 Namenaktien zu CHF 0.01 (Vorzugsaktien B) [bisher: 30'000'000 Namenaktien zu CHF 0.01 (Vorzugsaktien A) und 10'417'644 Namenaktien zu CHF 0.01]. Kapitalband gemäss näherer Umschreibung in den Statuten.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005869693 ↗

  6. SHAB published 26 Oct 2023 · legal date 18 Oct 2023

    Capital band adopted

    SHAB HR02-1005869693 ↗

  7. Announced 25 Apr 2025

    Round announced

    matched to a capital increase · high match confidence

    Announcement ↗

  8. SHAB published 14 Oct 2025 · legal date 7 Oct 2025

    Capital increase

    Confirmed round

    Paid in cash

    Nominal capital
    723’224.06 → 922’694.95
    Shares
    72’322’406 → 92’269’495
    New shares, % of post-step shares
    21.6% (19’947’089 new)
    Share classes
    10’417’644 × CHF 0.01 · 30’000’000 × CHF 0.01 Vorzugsaktien A · 51’851’851 × CHF 0.01 Vorzugsaktien B

    Aktienkapital neu: CHF 922'694.95 [bisher: CHF 723'224.06]. Liberierung Aktienkapital neu: CHF 922'694.95 [bisher: CHF 723'224.06]. Aktien neu: 10'417'644 Namenaktien zu CHF 0.01, 30'000'000 Namenaktien zu CHF 0.01 (Vorzugsaktien A) und 51'851'851 Namenaktien zu CHF 0.01 (Vorzugsaktien B) [bisher: 30'000'000 Namenaktien zu CHF 0.01 (Vorzugsaktien A), 31'904'762 Namenaktien zu CHF 0.01 (Vorzugsaktien B) und 10'417'644 Namenaktien zu CHF 0.01]. Ordentliche Kapitalerhöhung innerhalb Kapitalband unter Ausschöpfung des Maximalbetrages. [bisher: Kapitalband gemäss näherer Umschreibung in den Statuten.].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006457647 ↗

  9. SHAB published 14 Oct 2025 · legal date 7 Oct 2025

    Capital band adopted

    SHAB HR02-1006457647 ↗

  10. SHAB published 6 Jul 2026 · legal date 25 Jun 2026

    Capital increase

    Capital increased

    Issued from conditional capital

    Nominal capital
    922’694.95 → 927’196.84
    Shares
    92’269’495 → 92’719’684
    New shares, % of post-step shares
    0.5% (450’189 new)
    Share classes
    10’867’833 × CHF 0.01 · 30’000’000 × CHF 0.01 Vorzugsaktien A · 51’851’851 × CHF 0.01 Vorzugsaktien B

    Aktienkapital neu: CHF 927'196.84 [bisher: CHF 922'694.95]. Liberierung Aktienkapital neu: CHF 927'196.84 [bisher: CHF 922'694.95]. Aktien neu: 10'867'833 Namenaktien zu CHF 0.01, 30'000'000 Namenaktien zu CHF 0.01 (Vorzugsaktien A) und 51'851'851 Namenaktien zu CHF 0.01 (Vorzugsaktien B) [bisher: 30'000'000 Namenaktien zu CHF 0.01 (Vorzugsaktien A), 51'851'851 Namenaktien zu CHF 0.01 (Vorzugsaktien B) und 10'417'644 Namenaktien zu CHF 0.01].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • A small increment typical of employee share options.−1.0
    • Shares issued out of conditional capital, as when options are exercised.−1.0

    Classifier score 0.05 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006698390 ↗

Published by 8 Oct 2026